Dr. Eric Dinnerstein, MD

Dr. Dinnerstein practices at MaineHealth Maine Medical Center in Portland, Maine, part of MaineHealth.

Dr. Dinnerstein's NPI, 1740380153, was assigned on September 25, 2006. Dr. Dinnerstein holds Maine license MD17400.

Dr. Dinnerstein's primary practice is MaineHealth Maine Medical Center, at 22 Bramhall St, Portland, ME 04102 in Cumberland County. The practice phone is (207) 662-0111.

Dr. Dinnerstein's primary practice is MaineHealth Maine Medical Center in Portland, Maine, part of MaineHealth. Dr. Dinnerstein is also affiliated with UT Health Tyler. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Dr. Dinnerstein to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dinnerstein practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dinnerstein's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dinnerstein is licensed in Maine.

CMS data shows 402 Medicare services from Dr. Dinnerstein across 3 procedure codes in 2024, all of them office visits, for 313 Medicare patients. Medicare paid $33,758 for them. Every service was in an office.

CMS counts 313 Medicare patients who saw Dr. Dinnerstein in 2024. The largest group is 75 to 84, with 158 patients. 70% of them have high cholesterol, and 65% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dinnerstein's median patient age at 76, with 57% women.

In 2024, Dr. Dinnerstein wrote 1,632 Medicare Part D claims for 312 patients. 95% of them were for generic drugs. CMS names the drug for 1,508 of them, across 19 drugs with 11 or more claims each, at $116,103 in total drug cost. In 2023, CMS named 1,592 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Dinnerstein for performance year 2024, reported through an alternative payment model (APM). Dr. Dinnerstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dinnerstein as offering telehealth.

Dmand AI links 1 paper to Dr. Dinnerstein in 2013. Dr. Dinnerstein's most frequent co-authors are Fuyuki Hirashima, MD and Vijay M. Thadani, MD.

Dmand AI links Dr. Dinnerstein to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Alzheimer Disease, Delirium and Plaque, Amyloid. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Dinnerstein that name 2 trials.

CMS Open Payments shows 19 general payments to Dr. Dinnerstein from 4 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 57% of the total. Eli Lilly and Company paid the most, $1,416. It also lists 6 research payments totaling $4,008 from 2017 to 2023, naming 2 clinical trials.